Cargando…
The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases worldwide, presenting a great challenge to the public health systems due to high morbidity and mortality, because of frequent micro-/macro-vascular complications. Many treatment options are now available, with different effic...
Autores principales: | Guardado-Mendoza, Rodolfo, Prioletta, Annamaria, Jiménez-Ceja, Lilia M., Sosale, Aravind, Folli, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832818/ https://www.ncbi.nlm.nih.gov/pubmed/24273582 http://dx.doi.org/10.5114/aoms.2013.34991 |
Ejemplares similares
-
Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2021) -
Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2012) -
Glucose-dependent and Glucose-sensitizing Insulinotropic Effect of Nateglinide: Comparison
to Sulfonylureas and Repaglinide
por: Hu, Shiling, et al.
Publicado: (2001) -
Characterization of binding by repaglinide and nateglinide with glycated human serum albumin using high‐performance affinity microcolumns
por: Ovbude, Susan T., et al.
Publicado: (2022) -
Repaglinide, but Not Nateglinide Administered Supraspinally and Spinally Exerts an Anti-Diabetic Action in D-Glucose Fed and Streptozotocin-Treated Mouse Models
por: Sim, Yun-Beom, et al.
Publicado: (2013)